NOI - Olink Explore HT Proteomic Analysis for Sickle Cell Disease Study
Subject: NOI - Olink Explore HT Proteomic Analysis for Sickle Cell Disease StudySolicitation Number: 75N98026Q00281Notice Type: SOLICITNAICS: 541380Set-Aside: No Set aside usedNotice Published: 04-29-26Response Due: 05-13-26Agency: Department of Health and Human ServicesOffice: NATIONAL INSTITUTES OF HEALTHContact: CAPOBIANCO, NICHOLAS S This email address is being protected from spambots. You need JavaScript enabled to view it. Ph: (100) 000-0000Office Address: BETHESDA, MD 20892Place of Performance: Rockville, MD
Click for official SAM (FBO) notice, additional information, and accompanying attachments
The National Heart, Lung, and Blood Institute (NHLBI) intends to award a non-competitive purchase order for high-throughput proteomic analysis services using the Olink Explore HT platform. The requirement supports a longitudinal study investigating transthyretin (TTR) variants in sickle cell disease severity and includes quantification of over 5,400 proteins per sample. Services include standardized sample processing, assay execution, quality control, and delivery of normalized datasets compatible with previously generated study data. This notice is issued as a Notice of Intent for a non-competitive award; however, interested parties may submit capability statements demonstrating their ability to meet the Government’s requirement.